skip to the main content

Free Anti-Trastuzumab

Detecting the development of Anti-drug antibodies (ADAs) against Trastuzumab in patients being treated with Trastuzumab

Therapeutic Drug Monitoring (TDM) is to optimize biologic treatment for an individual patient. AFIAS Free Anti-Trastuzumab can detect the presence of anti-drug antibodies against Trastuzumab, requiring only a small amount of human serum or whole blood, and delivering results in a mere 10 minutes. This allows physicians to verify the presence of anti-drug antibodies immediately before the next administration.

  • CE

Available Instruments

About Using Reagent

  • Sample Types

    Serum, Whole blood
  • Reaction Time

    10 mins
  • Detection Range

    8-500 AU/mL
  • Intended Use

    Semi-quantitative determination of antibodies against Trastuzumab in human whole blood/serum

In Your Medical Field

AFIAS Free Anti-Trastuzumab detects anti-drug antibodies against Trastuzumab in just 10 minutes using a small amount of blood. It provides valuable insights into patients’ response to the treatment of Trastuzumab.